Johnson & Johnson MedTech’s orthopedics division, DePuy Synthes, has claimed an FDA clearance for its Velys surgical robot that expands its use into partial knee replacements. While total knee ...
DePuy Synthes faces a fine of $20 million after a jury found Johnson & Johnson’s orthopedics and neurosurgery device business guilty of infringing a patent belonging to a Utah-based orthopedic surgeon ...
Rasmussen Instruments, LLC (“Rasmussen”) won a $20M jury verdict against DePuy Synthes (“Depuy”), a part of Johnson & Johnson Medical Devices Companies. Rasmussen asserted Patent Nos. US 9,492,180 ...
PALM BEACH GARDENS, Fla., June 7, 2024 /PRNewswire/ -- Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has received 510(k) FDA ...
Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Knee Replacement Surgery Market - A Global and Regional Analysis: Focus on Procedure Type, Product Type, Application, End User, Country, and Region - ...
System Will Utilize the SIGMA(TM) HP Partial Knee Implant, Which Demonstrated Improved 12-Year Survivorship Compared to Class PALM BEACH GARDENS, Fla., June 7, 2024 /PRNewswire/ -- Today, Johnson & ...
(MENAFN- GlobeNewsWire - Nasdaq) Knee replacement surgery effectively addresses severe knee conditions like osteoarthritis, offering pain relief and improved mobility. The procedure sees high demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results